Upload
Featured Recent Articles Topics Login Upload

Search Results for ''

published presentations and documents on DocSlides.

Future HCV Treatment Paradigms
Future HCV Treatment Paradigms
by kittie-lecroy
Mark Sulkowski, MD . Professor of Medicine. Medic...
Treatment of Hepatitis C in patients with
Treatment of Hepatitis C in patients with
by tatyana-admore
thalassaemia. . Where . are we now?. Telaprevir ....
Discussion: Week 7 Phillip Keung
Discussion: Week 7 Phillip Keung
by colton732
Background. Primary biliary cirrhosis of the liver...
Table 1. Patients and tumor samples characteristics according to treatment program
Table 1. Patients and tumor samples characteristics according to treatment program
by ruby
Therapeutic. p. rogram . . Total. (%). Neuro - ...
Pediatric Ataxia David Lynch, MD PhD
Pediatric Ataxia David Lynch, MD PhD
by iris
DISCLAIMER. . . . The information provided by spea...
1 NAME OF THE MEDICINAL PRODUCT Forcaltonin 100 IU solution for inje
1 NAME OF THE MEDICINAL PRODUCT Forcaltonin 100 IU solution for inje
by clara
phosphatase or urinary hydroxyproline or deoxypyri...
A Markov Chain approach
A Markov Chain approach
by laobeast
for ranking treatments in network meta-analysis. A...
Access and affordability – Hepatitis C
Access and affordability – Hepatitis C
by olivia-moreira
Suzanne Hill . IPC. , December 2015. acknowledge...
Access and affordability – Hepatitis C
Access and affordability – Hepatitis C
by olivia-moreira
Suzanne Hill . IPC. , December 2015. acknowledge...
Discussion: Week 7
Discussion: Week 7
by test
Phillip Keung. Background. Primary biliary cirrho...
Evidence Based Aphasia Therapy
Evidence Based Aphasia Therapy
by calandra-battersby
after 15 years . Now What?. MACDG. November 4, 20...
State of the Art Therapy for HCV
State of the Art Therapy for HCV
by liane-varnes
Last Updated: February . 21, 2014. Robert G. Gish...
Fairy Lake Rx
Fairy Lake Rx
by tatyana-admore
Burn Monitoring. Stated objectives:. Mimic light ...
RO Water..New standards brings new concerns
RO Water..New standards brings new concerns
by olivia-moreira
Water quality requirement of draft AS/NZS 4187. I...
Cost of & Access to
Cost of & Access to
by kittie-lecroy
Molecularly Targeted Therapies as Barriers to Opt...
Non-adherence and its impact on treatment efficacy
Non-adherence and its impact on treatment efficacy
by jensen206
Alfonso Iorio, MD, PhD. Health Information Researc...
MEDPRAT Treatment Clusters: Improving Representation of Mission Medical Risk
MEDPRAT Treatment Clusters: Improving Representation of Mission Medical Risk
by oryan
February 3, 2021. Lawrence Leinweber, ZIN Technolo...
This resource summarizes the guidelines for prevention and treatment o
This resource summarizes the guidelines for prevention and treatment o
by quinn
Preferred OI Primary ProphylaxisNOTE: See AP See s...
Neratinib / Placebo treatment
Neratinib / Placebo treatment
by heartersh
0. 3. 6. 9. 12. 15. 18. 21. 24. Disease-free survi...
Treatment Preferences and Risk Tolerance Study
Treatment Preferences and Risk Tolerance Study
by alida-meadow
Pat Furlong, BSN, MS. Holly Peay, MS CGC. Vice Pr...
1 New Treatment Opportunity: Valganciclovir
1 New Treatment Opportunity: Valganciclovir
by tatyana-admore
Arax Bozadjian, PharmD. International AIDS Confer...
SOF/VEL + GS-9857 N = 33
SOF/VEL + GS-9857 N = 33
by taylor291
>. 18 years. Genotype 2, 3, 4, 5 or 6. HCV RNA...
Dengue : An epidemic disease
Dengue : An epidemic disease
by mary
Main cause of . arthropod-borne. Every year happen...
Carcinoma of the oesophagus
Carcinoma of the oesophagus
by luna
. . Squamous . oesophageal. cancer . is relative...
Any PRM at baseline Yes No
Any PRM at baseline Yes No
by lucy
39. 129. 100 . (91, 100). 98 . (95, 100). NRTI PRM...
Interventions against tuberculosis:
Interventions against tuberculosis:
by jade
The treatment of drug-susceptible. and drug-resist...
Summary 2011 Founded 2010
Summary 2011 Founded 2010
by eliza
in Houston. Vision: To be the leader in the develo...
Direct Health
Direct Health
by jacey
care Professional Communication , Clexane (enoxapa...
Insert presenter’s name, location and date of presentation
Insert presenter’s name, location and date of presentation
by SugarPlumFairy
Best Practices in Alaska. Overview. Tobacco Preven...
NS5A and polymerase inhibitors
NS5A and polymerase inhibitors
by LoveBug
Mark Sulkowski, MD. Professor of Medicine. Johns H...
Are (exogenous) interferons
Are (exogenous) interferons
by amey
really necessary?. Peter . Ferenci. Medical Univer...
C-EDGE Co-Infected: Phase 3 Study of
C-EDGE Co-Infected: Phase 3 Study of
by giovanna-bartolotta
C-EDGE Co-Infected: Phase 3 Study of Grazoprevi...
Binomial Effect Size Display
Binomial Effect Size Display
by tatiana-dople
What is it?. How do I prepare it?. What is It?. A...
How I use JAK2 inhibitors in
How I use JAK2 inhibitors in
by test
myeloproliferative. . neoplasms. navigating the ...
Efficacy of initial combination
Efficacy of initial combination
by natalia-silvester
antiretroviral therapy for HIV-1:. a meta-analysi...
Effect of antimicrobial treatment
Effect of antimicrobial treatment
by pamella-moone
on relapses of acute otitis media. Finland 100. ...
Midland Region
Midland Region
by aaron
All Boards Development Days. 10, 11 April, 2017. ...
Diflucan 100 Mg Tablets
Diflucan 100 Mg Tablets
by myesha-ticknor
how quickly does diflucan work. diflucan 150 mg p...
PHL-T-PBSP Presentation
PHL-T-PBSP Presentation
by andres689
MAY 26, 2021. OVERVIEW: . Global Fund Grant for TB...
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
EFFICACY AND SAFETY OF THE INTERFERON-FREE COMBINATION OF
by hezekiah
FALDAPREVIR (BI 201335) + BI 207127 ± RIBAVIRIN. ...